PMID: 16510029Mar 3, 2006Paper

Pharmacologic therapy for gastrointestinal bleeding due to portal hypertension and esophageal varices

Current Gastroenterology Reports
Don C Rockey

Abstract

Cirrhosis results in portal hypertension in many patients. The major complications of portal hypertension include development of ascites and esophageal or gastric varices. Varices lead to hemorrhage and death in a significant proportion of patients. This review focuses on the pharmacologic approach to management of portal hypertension in patients at risk of variceal hemorrhage, or those who have already had variceal bleeding. Pharmacologic therapy is used for 1) primary prevention of bleeding, 2) management of acute bleeding, and 3) prevention of recurrent bleeding (secondary prophylaxis). For acute esophageal variceal hemorrhage, a variety of pharmacologic agents are used, including somatostatin, octreotide, vapreotide, lanreotide, terlipressin, and vasopressin (with nitrates). For primary and secondary prevention of esophageal variceal hemorrhage, beta-blockers remain the mainstay therapy.

References

Dec 1, 1989·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J BoschJ Rodés
Oct 13, 1988·The New England Journal of Medicine·UNKNOWN North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices
May 1, 1985·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G Garcia-TsaoM Glickman
Nov 1, 1981·Gastrointestinal Endoscopy·K BeppuM Kobayashi
Sep 1, 1982·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D LebrecJ P Benhamou
Jul 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G D'AmicoJ Bosch
Aug 31, 1995·The New England Journal of Medicine·I BessonD Ribard
Sep 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·N D GraceJ Rodes
Jan 27, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A W SchneiderC P Klein
Apr 1, 1999·The New England Journal of Medicine·S K SarinN S Murthy
Sep 11, 1999·Journal of Gastroenterology and Hepatology·F H NgC S Cheng
Nov 24, 1999·The American Journal of Gastroenterology·N ChalasaniT D Boyer
Jan 22, 2000·Seminars in Liver Disease·G D'AmicoJ Bosch
Feb 3, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C MerkelA Gatta
Jul 25, 2000·Alimentary Pharmacology & Therapeutics·J VlachogiannakosA K Burroughs
Aug 29, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G H LoC K Lin
Oct 26, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C MerkelA Gatta
Feb 15, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·F SchepisG Raimondo
Mar 7, 2001·Gastroenterology·D A CorleyK Kerlikowske
Jun 16, 2001·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·M Angelico, R Lionetti
Sep 8, 2001·The New England Journal of Medicine·A I Sharara, D C Rockey
Jan 12, 2002·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·R de FranchisM Primignani
Mar 1, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Rafael BañaresLuis-Miguel Molinero
Dec 21, 2002·Alimentary Pharmacology & Therapeutics·G N IoannouD C Rockey
Dec 25, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Don C Rockey
Mar 26, 2003·The American Journal of Gastroenterology·Naga ChalasaniJianzhao Shen
Aug 27, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Gennaro D'AmicoUNKNOWN Cooperative Study Group
Feb 10, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Thomas D Boyer
Feb 10, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ulrich ThalheimerAndrew K Burroughs

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.